These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 39002515)
21. Novel aromatase inhibitors by structure-guided design. Ghosh D; Lo J; Morton D; Valette D; Xi J; Griswold J; Hubbell S; Egbuta C; Jiang W; An J; Davies HM J Med Chem; 2012 Oct; 55(19):8464-76. PubMed ID: 22951074 [TBL] [Abstract][Full Text] [Related]
22. From nonsteroidal aromatase inhibitors to multifunctional drug candidates: classic and innovative strategies for the treatment of breast cancer. Gobbi S; Cavalli A; Bisi A; Recanatini M Curr Top Med Chem; 2008; 8(10):869-87. PubMed ID: 18673172 [TBL] [Abstract][Full Text] [Related]
23. Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells. Su B; Chen S Bioorg Med Chem Lett; 2009 Dec; 19(23):6733-5. PubMed ID: 19854050 [TBL] [Abstract][Full Text] [Related]
24. Relevance of Aromatase Inhibitors in Breast Cancer Treatment. Sood A; Lang DK; Kaur R; Saini B; Arora S Curr Top Med Chem; 2021; 21(15):1319-1336. PubMed ID: 34218783 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer. Fayad E; Binjawhar DN; Ageeli AA; Alshaya DS; Elsaid FG; Mahmoud AY; Radwan EM; Elian Sophy MA; Mahdy AR Future Med Chem; 2024; 16(8):707-721. PubMed ID: 38488019 [TBL] [Abstract][Full Text] [Related]
26. Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors. Sağlık BN; Şen AM; Evren AE; Çevik UA; Osmaniye D; Kaya Çavuşoğlu B; Levent S; Karaduman AB; Özkay Y; Kaplancıklı ZA Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):353-362. PubMed ID: 32681791 [TBL] [Abstract][Full Text] [Related]
27. Biochemical and biological characterization of a novel anti-aromatase coumarin derivative. Chen S; Cho M; Karlsberg K; Zhou D; Yuan YC J Biol Chem; 2004 Nov; 279(46):48071-8. PubMed ID: 15358790 [TBL] [Abstract][Full Text] [Related]
28. Aromatase, aromatase inhibitors, and breast cancer. Chumsri S; Howes T; Bao T; Sabnis G; Brodie A J Steroid Biochem Mol Biol; 2011 May; 125(1-2):13-22. PubMed ID: 21335088 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells. Su B; Landini S; Davis DD; Brueggemeier RW J Med Chem; 2007 Apr; 50(7):1635-44. PubMed ID: 17315855 [TBL] [Abstract][Full Text] [Related]
30. Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy. Amaral C; Varela C; Azevedo M; da Silva ET; Roleira FM; Chen S; Correia-da-Silva G; Teixeira N J Steroid Biochem Mol Biol; 2013 May; 135():51-9. PubMed ID: 23318878 [TBL] [Abstract][Full Text] [Related]
31. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation. Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642 [TBL] [Abstract][Full Text] [Related]
32. Novel sulfonanilide analogs decrease aromatase activity in breast cancer cells: synthesis, biological evaluation, and ligand-based pharmacophore identification. Su B; Tian R; Darby MV; Brueggemeier RW J Med Chem; 2008 Mar; 51(5):1126-35. PubMed ID: 18271519 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles. Banday AH; Saeed BA; Al-Masoudi NA Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853 [TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities. Lv W; Liu J; Skaar TC; Flockhart DA; Cushman M J Med Chem; 2015 Mar; 58(6):2623-48. PubMed ID: 25751283 [TBL] [Abstract][Full Text] [Related]
35. Aromatase inhibitors in the treatment of breast cancer. Brueggemeier RW; Hackett JC; Diaz-Cruz ES Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851 [TBL] [Abstract][Full Text] [Related]
36. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer. Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946 [TBL] [Abstract][Full Text] [Related]
37. Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer. Spinello A; Martini S; Berti F; Pennati M; Pavlin M; Sgrignani J; Grazioso G; Colombo G; Zaffaroni N; Magistrato A Eur J Med Chem; 2019 Apr; 168():253-262. PubMed ID: 30822713 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, In vitro and In silico Studies of Novel Bis-triazolopyridopyrimidines from Curcumin Analogues as Potential Aromatase Agents. Gomha SM; El-Sayed AAA; Zaki MEA; Alrehaily A; Elbadawy HM; Al-Shahri ABA; Alsenani SR; Abouzied AS Chem Biodivers; 2024 Aug; 21(8):e202400701. PubMed ID: 38829745 [TBL] [Abstract][Full Text] [Related]
39. Aromatase inhibition: translation into a successful therapeutic approach. Geisler J; Lønning PE Clin Cancer Res; 2005 Apr; 11(8):2809-21. PubMed ID: 15837728 [TBL] [Abstract][Full Text] [Related]
40. Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women. Avvaru SP; Noolvi MN; Aminbhavi TM; Chkraborty S; Dash A; Shukla SS Mini Rev Med Chem; 2018; 18(7):609-621. PubMed ID: 29090666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]